Cardio Diagnostics Holdings Stock Probability of Future Stock Price Finishing Over 2.08
| CDIO Stock | USD 0.30 0.01 3.23% |
Cardio |
Cardio Diagnostics Target Price Odds to finish over 2.08
The tendency of Cardio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 2.08 or more in 90 days |
| 0.30 | 90 days | 2.08 | close to zero percent |
Based on a normal probability distribution, the odds of Cardio Diagnostics to move over $ 2.08 or more in 90 days from now is close to zero percent (This Cardio Diagnostics Holdings probability density function shows the probability of Cardio Stock to fall within a particular range of prices over 90 days) . Probability of Cardio Diagnostics price to stay between its current price of $ 0.30 and $ 2.08 at the end of the 90-day period is about 28.2 .
Given the investment horizon of 90 days the stock has the beta coefficient of 4.96 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Cardio Diagnostics will likely underperform. Additionally Cardio Diagnostics Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Cardio Diagnostics Price Density |
| Price |
Predictive Modules for Cardio Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cardio Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cardio Diagnostics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cardio Diagnostics is not an exception. The market had few large corrections towards the Cardio Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cardio Diagnostics Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cardio Diagnostics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.47 | |
β | Beta against Dow Jones | 4.96 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.006 |
Cardio Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cardio Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cardio Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cardio Diagnostics had very high historical volatility over the last 90 days | |
| Cardio Diagnostics has some characteristics of a very speculative penny stock | |
| Cardio Diagnostics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 17.07 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 901. | |
| Cardio Diagnostics Holdings currently holds about 9.66 M in cash with (5.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cardio Diagnostics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Ryan Smith Named as Chief Digital and Information Officer at Intermountain Health |
Cardio Diagnostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cardio Stock often depends not only on the future outlook of the current and potential Cardio Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardio Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.7 M | |
| Cash And Short Term Investments | 1.3 M |
Cardio Diagnostics Technical Analysis
Cardio Diagnostics' future price can be derived by breaking down and analyzing its technical indicators over time. Cardio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cardio Diagnostics Holdings. In general, you should focus on analyzing Cardio Stock price patterns and their correlations with different microeconomic environments and drivers.
Cardio Diagnostics Predictive Forecast Models
Cardio Diagnostics' time-series forecasting models is one of many Cardio Diagnostics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cardio Diagnostics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cardio Diagnostics
Checking the ongoing alerts about Cardio Diagnostics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cardio Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cardio Diagnostics had very high historical volatility over the last 90 days | |
| Cardio Diagnostics has some characteristics of a very speculative penny stock | |
| Cardio Diagnostics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 17.07 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 901. | |
| Cardio Diagnostics Holdings currently holds about 9.66 M in cash with (5.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cardio Diagnostics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Ryan Smith Named as Chief Digital and Information Officer at Intermountain Health |
Check out Cardio Diagnostics Backtesting, Cardio Diagnostics Valuation, Cardio Diagnostics Correlation, Cardio Diagnostics Hype Analysis, Cardio Diagnostics Volatility, Cardio Diagnostics History as well as Cardio Diagnostics Performance. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Revenue Per Share 0.002 | Quarterly Revenue Growth 3.562 | Return On Assets (0.98) | Return On Equity (2.93) |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.